PanTera
Healthcare & Life Sciences
Recent Finacing
Hybrid A
Recent Raise
$139.7M
PanTera is a Belgian company focused on producing the radioisotope actinium-225 for use in Targeted Alpha Therapy for cancer treatment.
Focus Areas
radioisotope production
actinium-225
cancer treatment
Targeted Alpha Therapy
state-of-the-art facility
global shortage
Investors
